7-Phenylpyrrolo[2,1-f][1,2,4]triazin-2-ol
95%
- Product Code: 64671
CAS:
1318629-63-8
| Molecular Weight: | 211.22 g./mol | Molecular Formula: | C₁₂H₉N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22573649 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of various pharmaceutical agents. Its unique structure makes it valuable in the development of compounds that target specific enzymes or receptors, particularly in the treatment of diseases such as cancer and inflammatory disorders. Researchers often explore its derivatives for their potential biological activities, including kinase inhibition, which is crucial in regulating cell signaling pathways. Additionally, it is investigated for its role in creating novel therapeutic agents with improved efficacy and reduced side effects. Its application extends to drug discovery programs, where it contributes to the optimization of lead compounds for clinical trials.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿20,520.00 |
+
-
|
7-Phenylpyrrolo[2,1-f][1,2,4]triazin-2-ol
This compound is primarily utilized in the field of medicinal chemistry, where it serves as a key intermediate in the synthesis of various pharmaceutical agents. Its unique structure makes it valuable in the development of compounds that target specific enzymes or receptors, particularly in the treatment of diseases such as cancer and inflammatory disorders. Researchers often explore its derivatives for their potential biological activities, including kinase inhibition, which is crucial in regulating cell signaling pathways. Additionally, it is investigated for its role in creating novel therapeutic agents with improved efficacy and reduced side effects. Its application extends to drug discovery programs, where it contributes to the optimization of lead compounds for clinical trials.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :